Transcript ICD-11 Internal Medicine Advisory Group ppt

Julie Rust
Managing Editor
Internal Medicine TAG
Chair: Prof. Kentaro Sugano (JP)
Co-chair: Dr. Rodney Franklin (UK)
Cardiovascular
Endocrinology
Gastroenterology
Haematology
Hepatology
Nephrology
Respiratory
Rheumatology
Structure of Working Groups
Working Group
Chairs
Managing
editor
Nephrology
Y Iino (JP)
Lesley Stevens (USA)
-
Rheumatology
Jonathan Kay (USA)
Masayoshi Harigai (JP)
AW-Dahl
(Musculoskeletal
TAG)
Gastroenterology
P Malfertheiner (FRG)
S. Miura (JP)
J Akiyama
Hepatology
EB Keefe (USA)
T Tomiya
Respiratory
DH Ingbar (USA)
S. Hashimoto (JP)
-
Hematology
W Fibbe (Netherland)
-
Endocrinology &
Metabolism
A Shimatsu (JP)
N Tajima (JP)
-
Cardiovascular
BJ Gersh (USA)
T Kohro

Review of code hierarchy and content model
in start up list of iCAT:
◦
◦
◦
◦

Clinical currency
New diseases/disorders and location
Outdated terminology
Need for further or less granularity
Managing editor guidance on:
◦ Conventions of a statistical classification
◦ Evidence based and transparent process




Different approaches in groups:
◦ Proposal drafted with support of professional specialist
society
◦ Sub-specialties within each group work on specific topic
areas, with in-group peer review
◦ Combination of above
Communication via meetings, teleconferences
and email.
Draft proposal submitted to IM TAG managing
editors for editing/commenting – iterative
process (internal and external)
Finalised proposal entered into collaborative
authoring tool (iCAT)
◦ Rare Diseases TAG
 Congenital anomalies of digestive system
 Metabolic diseases (liver and endocrine)
 Congenital and paediatric cardiology
◦ Dermatology TAG
 Inflammatory arthritis – psoriatic arthritis
 Myositis
◦ Musculoskeletal TAG
 Osteoarthritis
 Inflammatory spondyloarthritis
◦ Separation of previously combined sites in first
anatomical axis, eg oesophagus, stomach and
duodenum
◦ Standardisation of second axis within each
anatomical site
◦ Inclusion of functional gastrointestinal disorders
◦ Liver diseases – expanded with inclusion of new
categories for NAFLD, metabolic and transporter
liver diseases, infectious liver diseases
◦ ‘Claim’ for haemorrhoids, gastrointestinal varices,
hepatitis





Inclusion of acute kidney disease/acute
kidney injury
Update of ‘renal osteodystrophy’ to ‘mineral
and bone disease’
Addition of genetic linkages, via the content
model, for cystic kidney disease
Expansion of renal dialysis status codes, to
include details on modality and access
Expansion of codes for glomerular diseases,
to add specificity on pathology findings





Update of the classification of inflammatory
arthropathies
Reference to the Chapel Hill International
Consensus Conference classification of systemic
vasculitis.
Change name of “Dermatopolymyositis” to
“Idiopathic inflammatory myopathies’, change of
axes and introduction of further granularity.
New category for autoinflammatory syndromes
Reduction in eponyms for code titles

Examples of proposals for update to ICD-10:
◦ Removal of the term, code and dagger/asterisk link
for ‘arthropathic psoriasis’ from the Dermatology
chapter, and expand the codes for psoriatic arthritis
in the Musculoskeletal chapter.
◦ Revisions to the classification of spondyloarthritis,
with a separation of axial and peripheral
spondyloarthritis.



Global project – international representation
and balance in TAGs/WGs, limited Australian
input
Opportunity for classification experts to work
with ‘horizontal’ TAGs of mortality,
morbidity, functioning and safety/quality (for
linearisations)
Planning for beta phase – education of key
Australian clinical groups and stakeholders
on how they can contribute and comment